Clinical trials: Telogen Effluvium
Gut Dysbiosis, Telogen Effluvium
Gut Microbiota and Trichoscopic Changes in Women With Telogen Effluvium on a Multifactorial Drinkable Nutraceutical: A Retrospective Observational Study
Telogen effluvium (TE) is a common cause of diffuse, non-scarring hair shedding in women. It is often triggered by physiological stress, nutritional deficiencies, illness or hormonal changes.
- Conditions
- Gut Dysbiosis, Telogen Effluvium, Hair Loss
- Trial name
- NCT07869199
- Testing
- Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women.
- Where
- 2 sites in Spain
- Volunteers
- 30 people
- Sponsor
- Olistic Research Labs S.L.
Telogen Effluvium
Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists
The purpose of this clinical trial is to evaluate the efficacy of Olistic© Next Women, a nutraceutical supplement, compared with placebo in improving hair loss in patients undergoing treatment with GLP-1/GIP agonists.
- Trial name
- NCT07484061
- Testing
- Drinkable multifactorial food supplement containing vitamins, minerals, amino acids, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women +45.
- Where
- Spain
- Volunteers
- 40 people
- Sponsor
- Olistic Research Labs S.L.
Telogen Effluvium
Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment
This is a randomized, double-blind, controlled clinical trial investigating the efficacy and safety of millet seed extract capsules in treating telogen effluvium in female patients.
- Trial name
- NCT07348120
- Testing
- Millet Seed Extract group, Biotin group
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Kasr El Aini Hospital
Telogen Effluvium, Female Pattern Hair Loss
Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
The primary objective of the study is to assess the safety and efficacy of DA-001 as a treatment for Hair Shedding Reduction and Hair Re-Growth
- Conditions
- Telogen Effluvium, Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia, Male Pattern Baldness
- Trial name
- NCT06648850
- Testing
- DA-001, Phenylephrine, DA-001 Topical + DA-005 Oral (HIF-1α supplement)
- Volunteers
- 1,120 people
- Sponsor
- Applied Biology, Inc.
Telogen Effluvium, Androgenetic Alopecia
Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.
The goal of this observational study is to learn about the effects of anti-hair loss shampoo in subjects over the age of 18 who use shampoo to treat their hair loss caused by telogen effluvium (TE) and androgenetic alopecia…
- Trial name
- NCT07433933
- Where
- Spain
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Lacer S.A.
Androgenetic Alopecia (AGA), Telogen Effluvium
Therapeutic Potential of Topical Latanoprost Acid in Hair Loss - Pilot, Proof-of-concept Study
This pilot study evaluates the efficacy, safety, and tolerability of topical latanoprost acid in adult women with female pattern hair loss, with a minority of participants diagnosed with chronic telogen effluvium.
- Conditions
- Androgenetic Alopecia (AGA), Telogen Effluvium, Female Pattern Hair Loss, Androgenic Alopecia
- Trial name
- NCT07412587
- Testing
- Latanoprost acid-containing cosmetic topical solution
- Volunteers
- 29 people
- Sponsor
- Medical University of Warsaw
Androgenetic Alopecia (AGA), Chronic Telogen Effluvium
Evaluation of the Dietary Supplement Efficacy Against Hair Loss in Subjects Suffering From Hair Loss
The goal of this study was to learn if dietary supplement in capsules and drinkable works to help hair loss in volunteers with chronic telogen effluvium and androgenetic alopecia and learn about its safety.
- Trial name
- NCT07358403
- Testing
- Dietary supplement capsule use for hair loss, Dietary supplement drinklable use for hair loss
- Where
- Italy
- Volunteers
- 240 people, healthy volunteers welcome
- Sponsor
- Lacer S.A.
Telogen Effluvium
Clinical Evaluation of a Nutraceutical Supplement (Olistic Women) for Hair Growth and Hair Loss in Human Volunteers
Hair loss is a multifactorial and complex condition influenced by factors such as hormonal changes, vitamin and mineral deficiencies, genetic predisposition, oxidative stress, aging, inflammation, and psychological stress.
- Trial name
- NCT07111312
- Testing
- Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women.
- Where
- 2 sites in Spain
- Volunteers
- 106 people
- Sponsor
- Olistic Research Labs S.L.
Telogen Effluvium, Healthy
Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium
The study is aimed to assess the efficacy of a food supplement in reducing hair loss and accelerating the physiological growth in terms of elongation in female subjects showing acute telogen effluvium.
- Trial name
- NCT06545552
- Testing
- An oral formulation of green tea extract, bamboo shoot extract and selenium-enriched yeast
- Where
- Italy
- Volunteers
- 66 people, healthy volunteers welcome
- Sponsor
- Activ'inside
Telogen Effluvium
BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.
Study phase III, randomized, double-dummy, placebo controlled, single-center, of regarding the non-inferiority of the medication BL3000, when compared to Pantogar® treatment of telogen effluvium in women.
- Trial name
- NCT04880889
- Testing
- BL 3000, Reference Pantogar
- Volunteers
- 326 people
- Sponsor
- Biolab Sanus Farmaceutica
Androgenetic Alopecia, Telogen Effluvium
PAI-1 Expression in Non-scarring Hair Loss
This study will investigate whether subjects who suffer from hair loss have increased levels of PAI-1 compared to age-matched control subjects.
- Conditions
- Androgenetic Alopecia, Telogen Effluvium, Alopecia Areata
- Trial name
- NCT02548689
- Where
- United States
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Northwestern University
Covid19, Telogen Effluvium
COVID-19 Induced Telogen Effluvium
This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection
- Conditions
- Covid19, Telogen Effluvium, SARS-CoV Infection, Alopecia
- Trial name
- NCT04834102
- Testing
- Blood Tests
- Where
- Turkey (Türkiye)
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Istanbul Medeniyet University
Telogen Effluvium
Efficacy Study of Cosmetic Product Against Telogen Effluvium on Women
Telogen effluvium (TE) is one of the most common causes of non-scarring diffuse hair loss, defined as global diminution of hair with no formation of areas completely bald.
- Trial name
- NCT04652232
- Testing
- RV3466F lotion
- Where
- 2 sites in France
- Volunteers
- 100 people
- Sponsor
- Pierre Fabre Dermo Cosmetique
Androgenetic Alopecia, Androgenic Alopecia
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss
To demonstrate that the ALRV5XR multi-molecular targeting treatment regimen of a daily shampoo, conditioner, topical serum and oral supplement is superior to placebo in promoting hair growth as assessed by change in hair density…
- Conditions
- Androgenetic Alopecia, Androgenic Alopecia, Telogen Effluvium, Thinning Hair
- Trial name
- REBOOT-MEN (NCT04450589)
- Testing
- ALRV5XR, ALRV5XR Conditioner, ALRV5XR Hair Follicle Serum (Nutriment)
- Where
- United States
- Volunteers
- 46 people
- Sponsor
- Arbor Life Labs
Androgenetic Alopecia, Androgenic Alopecia
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
To demonstrate that the ALRV5XR multi-molecular targeting treatment regimen of a daily shampoo, conditioner, topical serum and oral supplement is superior to placebo in promoting hair growth as assessed by change in hair density…
- Conditions
- Androgenetic Alopecia, Androgenic Alopecia, Telogen Effluvium, Thinning Hair
- Trial name
- REBOOT-WOMEN (NCT04450602)
- Testing
- ALRV5XR, ALRV5XR Conditioner, ALRV5XR Hair Follicle Serum (Nutriment)
- Where
- United States
- Volunteers
- 46 people
- Sponsor
- Arbor Life Labs
Telogen Effluvium
Demonstration of the Presence of a Carbonyl Stress in the Hair Follicles of Postpartum Women
In this study, the investigator will try to highlight the presence of carbonyl compounds in the hair follicles of postpartum women by comparing these compounds before and after delivery.
- Trial name
- NCT04237402
- Testing
- Hair follicles sampling
- Where
- France
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Pierre Fabre Dermo Cosmetique
Chronic Telogen Effluvium
Efficacy and Safety of Neosil on Chronic Effluvium
The purpose of this study is to evaluate the efficacy of Neosil in the treatment of chronic effluvium
- Trial name
- NCT03659201
- Testing
- Neosil complete, Pantogar, Neosil
- Where
- Brazil
- Volunteers
- 232 people
- Sponsor
- EMS
Effluvium; Telogen
Demonstration of Carbonyl Stress on Hair Follicles
In this study, the investigator will try to highlight the presence of carbonyl compounds in the hair follicles of women with telogen effluvium (ET) linked to stress of various origins (fatigue, infectious diseases, emotional…
- Trial name
- NCT03414476
- Testing
- Hair follicles sampling
- Where
- 6 sites in France
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Pierre Fabre Dermo Cosmetique
Telogen Effluvium
Evaluation of Tolerance and Trichological Efficacy of a Food Supplement
Controlled, randomized, double blind study, for the evaluation of tolerance and trichological efficacy of a food supplement: Bioscalin® new formulation versus reference formulation currently on the market and placebo
- Trial name
- NCT03272750
- Testing
- Bioscalin® new formulation with Galeopsis Segetum, Reference product
- Volunteers
- 51 people, healthy volunteers welcome
- Sponsor
- Derming SRL